What is Rekvina Laboratories share price return in the past 10 years?

Rekvina Laboratories Ltd share price has declined -6.5% annually (CAGR) over the past ten years.

What is the P/E ratio of Rekvina Laboratories?

The latest standalone P/E ratio of Rekvina Laboratories as of 13-Dec-2021 is 0.00.

What is the P/B ratio of Rekvina Laboratories?

The latest standalone P/B ratio of Rekvina Laboratories as of 13-Dec-2021 is 31.29.

What is the 52-week high and low of Rekvina Laboratories?

The 52-week high of Rekvina Laboratories is Rs. 4.50 and the 52-week low is Rs. 4.50.

Rekvina Laboratories Ltd - Stock Valuation and Financial Performance

Name: Rekvina Laboratories
Brand: Rekvina Laboratories

BSE: 526075 | NSE: | Trading | Small Cap

Place order

DeciZen - make an informed investing decision on Rekvina Labs

Based on:

Data

M-Cap below 100cr DeciZen not available

Rekvina Laboratories stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

2.7 Cr.

52-wk low:

4.5

52-wk high:

4.5

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

The key valuation ratios of Rekvina Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Rekvina Labs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
ROCE % ⓘ	0%	-5.1%	-1.3%	4.2%	2.6%	3.4%	0.7%	-10.4%	-3.3%	-12.6%	-
Value Creation Index ⓘ	NA	-1.4	-1.1	-0.7	-0.8	-0.8	-1.0	-1.7	-1.2	-1.9	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0.1	0.1	0.1	0	0.1	0	0	0
Sales YoY Gr.	-	NA	NA	NA	0%	0%	-62.5%	100%	-100%	NA	-
Adj EPS ⓘ	0	-0.1	-0	0	0	0	0	-0.1	-0	-0.1	0
YoY Gr.	-	NA	NA	NA	0%	33.3%	-75%	-1000%	NA	NA	-
BVPS (₹) ⓘ	0	1.1	1	1.1	1.1	1.1	0.9	0.8	0.8	0.7	0.1
Adj Net Profit ⓘ	0	0	0	0	0	0	0	-0.1	0	-0.1	0
Cash Flow from Ops. ⓘ	0	0	0	0	0	0	0	0	0	0	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	-0.5	-0.2	16.9	-8.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-100%	-100%	NA
Adj EPS ⓘ	NA	-234.1%	-335.1%	NA
BVPSⓘ	NA	-9.3%	-10.4%	-17.3%
Share Price	-6.5%	-2.3%	4.3%	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
Return on Equity % ⓘ	-5.1	-1.3	2.5	2.6	3.3	0.6	-10.6	-3.9	-17.9	0
Op. Profit Mgn % ⓘ	0	0	38.6	26.2	35.9	15.4	-89.9	0	0	NAN
Net Profit Mgn % ⓘ	0	0	19.5	21.2	28.8	12.2	-90.1	0	0	NAN
Debt to Equity ⓘ	0	0	0	0	0	0	0	0.4	0.5	-
Working Cap Days ⓘ	0	0	1,453	1,697	2,004	5,059	2,549	0	0	0
Cash Conv. Cycle ⓘ	0	0	-6,422	-67,219	0	-1,342	-4,940	0	0	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Rekvina Laboratories Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	0.1	-
Reserves (₹ Cr.) ⓘ	-3	-
P/BV ⓘ	31.29	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	4.50 / 4.50
All Time Low / High (₹)	0.50 / 77.75
Market Cap (₹ Cr.)	2.7
Equity (₹ Cr.)	3
Face Value (₹)	5
Industry PE ⓘ	78.4

Management X-Ray of Rekvina Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Rekvina Labs

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Rekvina Labs

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Sales	0	0	0.08	0.08	0.08	0.03	0.06	0	0
Operating Expenses ⓘ	0.04	0.01	0.05	0.06	0.05	0.03	0.12	0.05	0.10
Manufacturing Costs	0	0	0	0	0	0	0	0	0
Material Costs	0	0	0	0	0	0	0	0	0
Employee Cost	0	0	0	0	0	0.01	0.01	0	0
Other Costs ⓘ	0.04	0.01	0.05	0.06	0.05	0.02	0.11	0.05	0.10
Operating Profit ⓘ	-0.04	-0.01	0.03	0.02	0.03	0.01	-0.06	-0.05	-0.10
Operating Profit Margin (%)	-	-	38.6%	26.2%	35.9%	15.4%	-89.9%	-	-
Other Income ⓘ	0	0	0	0	0	0	0	0.03	0.02
Interest ⓘ	0	0	0.02	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.04	-0.01	0.02	0.02	0.03	0	-0.06	-0.02	-0.08
Tax ⓘ	0	0	0	0	0.01	0	0	0	0
Profit After Tax	-0.04	-0.01	0.02	0.02	0.02	0	-0.06	-0.02	-0.08
PAT Margin (%)	-	-	19.5%	21.2%	28.8%	12.2%	-90.0%	-	-
Adjusted EPS (₹)	-0.1	0.0	0.0	0.0	0.0	0.0	-0.1	0.0	-0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Equity and Liabilities
Shareholders Fund	0.63	0.63	0.64	0.66	0.68	0.56	0.50	0.49	0.41
Share Capital ⓘ	3.01	3.01	3.01	3.01	3.01	3.01	3.01	3.01	3.01
Reserves ⓘ	-2.38	-2.39	-2.37	-2.36	-2.33	-2.45	-2.51	-2.53	-2.61
Minority Interest	0	0	0	0	0	0	0	0	0
Debt	0	0	0	0	0	0.01	0.01	0.17	0.21
Long Term Debt	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0.01	0.01	0.17	0.21
Trade Payables	0.01	0	0.02	0.06	0.08	0.09	0.13	0.13	0.19
Others Liabilities ⓘ	0	0	0	0	0.01	0	0	0	0
Total Liabilities ⓘ	0.64	0.63	0.66	0.73	0.77	0.66	0.64	0.79	0.80
Fixed Assets
Gross Block	0.51	0.51	0.51	0.51	0.51	0.51	0.51	0.51	0.51
Accumulated Depreciation	0.24	0.24	0.24	0.24	0.24	0.37	0.37	0.37	0.37
Net Fixed Assetsⓘ	0.27	0.27	0.27	0.27	0.27	0.15	0.15	0.15	0.15
CWIP ⓘ	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Inventories	0	0	0	0	0	0	0	0	0
Trade Receivables	0	0.04	0.08	0.16	0.22	0.25	0.28	0.25	0.26
Cash Equivalents	0	0	0	0	0	0	0.03	0.13	0.15
Others Assetsⓘ	0.32	0.27	0.26	0.24	0.23	0.21	0.14	0.21	0.20
Total Assets ⓘ	0.64	0.63	0.66	0.73	0.77	0.66	0.64	0.79	0.80

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Cash Flow From Operating Activity ⓘ	0	0	-0.02	-0.02	-0.04	0.01	-0.02
PBT ⓘ	-0.01	0.02	0.03	0	-0.06	-0.02	-0.08
Adjustment ⓘ	0	0	0	0	0	0	0
Changes in Working Capital ⓘ	0.01	-0.02	-0.04	-0.03	0.01	0.03	0.06
Tax Paid ⓘ	0	0	-0.01	0	0	0	0
Cash Flow From Investing Activity ⓘ	0	0	0.02	0.02	0.07	-0.07	0
Capex	0	0	0	0	0	0	0
Net Investments	0	0	0	0	0	-0.07	0
Others ⓘ	0	0	0.02	0.02	0.07	0	0
Cash Flow From Financing Activityⓘ	0	0	0	0.01	0	0.16	0.04
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0.01	0	0.16	0.04
Net Cash Flow ⓘ	0	0	0	0	0.03	0.10	0.01

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Ratios
ROE (%)	-5.84	-1.28	2.5	2.6	3.34	0.64	-10.61	-3.89	-17.92
ROCE (%)	-5.84	-1.28	4.95	3.22	4.16	0.81	-10.39	-3.28	-12.59
Asset Turnover Ratio	0	0	0.13	0.12	0.1	0.05	0.1	0	0
PAT to CFO Conversion(x)	N/A	N/A	0	0	-1	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	0	268	554	902	2,635	1,534	0	0
Inventory Days	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0

Rekvina Laboratories Ltd Stock News

Rekvina Laboratories Ltd FAQs

What is the share price of Rekvina Labs?

Company share prices are keep on changing according to the market conditions. The closing price of Rekvina Labs on 13-Dec-2021 18:01 is ₹4.50.

What is the market cap of Rekvina Labs?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 13-Dec-2021 18:01 the market cap of Rekvina Labs stood at ₹2.71.